| ACI/N |
systolic blood pressure |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
arterial blood pressure trait |
both |
125.0 days-132.0 days |
220 |
|
141.0 |
mmHg |
0.88 |
13.0 |
tail cuff piezoplethysmography |
|
|
6-8 readings per sitting |
11671 |
114 |
| BUF/N |
systolic blood pressure |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
arterial blood pressure trait |
both |
125.0 days-132.0 days |
220 |
|
132.0 |
mmHg |
0.07 |
1.1 |
tail cuff piezoplethysmography |
|
|
6-8 readings per sitting |
11675 |
114 |
| SHR/FubRkb |
systolic blood pressure |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
arterial blood pressure trait |
not specified |
173.0 days
| 10 |
|
175.3 |
mmHg |
2.8 |
8.85 |
tail cuff piezoplethysmography |
0.0 |
|
12-18 recordings on 3 consecutive days |
11688 |
117 |
| MNS/Gib |
systolic blood pressure |
control condition |
Zagato et al., 2000, Hypertension, 36(5), 734-9 |
arterial blood pressure trait |
not specified |
84.0 days-112.0 days |
17 |
serial mean |
131.2 |
mmHg |
1.1 |
4.54 |
tail cuff piezoplethysmography |
4 readingsin 4 sessions |
|
W+W BP recorder |
11725 |
122 |
| MHS |
systolic blood pressure |
control condition |
Parenti P, etal., Hypertension. 1986 Oct;8(10):932-9. doi: 10.1161/01.hyp.8.10.932. |
arterial blood pressure trait |
male |
28.0 days
| 11 |
|
122.0 |
mmHg |
7.6 |
25.21 |
tail cuff piezoplethysmography |
0.0 |
|
|
110941 |
3173 |
| WKY/N |
systolic blood pressure |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
arterial blood pressure trait |
both |
125.0 days-132.0 days |
220 |
|
143.0 |
mmHg |
0.74 |
11.0 |
tail cuff piezoplethysmography |
|
|
6-8 readings per sitting |
11672 |
114 |
| WN/N |
systolic blood pressure |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
arterial blood pressure trait |
both |
125.0 days-132.0 days |
220 |
|
130.0 |
mmHg |
0.03 |
0.5 |
tail cuff piezoplethysmography |
|
|
6-8 readings per sitting |
11676 |
114 |
| MWF/FubRkb |
systolic blood pressure |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
arterial blood pressure trait |
not specified |
173.0 days
| 18 |
|
145.1 |
mmHg |
1.1 |
4.67 |
tail cuff piezoplethysmography |
0.0 |
|
12-18 recordings on 3 consecutive days |
11690 |
117 |
| MR/N |
systolic blood pressure |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
arterial blood pressure trait |
both |
125.0 days-132.0 days |
220 |
|
130.0 |
mmHg |
0.06 |
0.9 |
tail cuff piezoplethysmography |
|
|
6-8 readings per sitting |
11674 |
114 |
| MWF-Chr 6SHR/Rkb |
systolic blood pressure |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
arterial blood pressure trait |
not specified |
173.0 days
| 19 |
|
151.0 |
mmHg |
1.6 |
6.97 |
tail cuff piezoplethysmography |
0.0 |
|
12-18 recordings on 3 consecutive days |
11689 |
117 |
| MNS |
systolic blood pressure |
control condition |
Parenti P, etal., Hypertension. 1986 Oct;8(10):932-9. doi: 10.1161/01.hyp.8.10.932. |
arterial blood pressure trait |
male |
28.0 days
| 11 |
|
114.0 |
mmHg |
5.5 |
18.24 |
tail cuff piezoplethysmography |
0.0 |
|
|
110942 |
3173 |
| MHS/Gib |
systolic blood pressure |
control condition |
Ferrari P, etal., Biochim Biophys Acta. 1992 Oct 19;1111(1):111-9. doi: 10.1016/0005-2736(92)90280-y. |
arterial blood pressure trait |
male |
49.0 days-56.0 days |
|
|
168.4 |
mmHg |
1.1 |
|
tail cuff piezoplethysmography |
0.0 |
|
|
110331 |
3172 |
| MNS/Gib |
systolic blood pressure |
control condition |
Ferrari P, etal., Biochim Biophys Acta. 1992 Oct 19;1111(1):111-9. doi: 10.1016/0005-2736(92)90280-y. |
arterial blood pressure trait |
male |
49.0 days-56.0 days |
|
|
132.1 |
mmHg |
1.2 |
|
tail cuff piezoplethysmography |
0.0 |
|
|
110332 |
3172 |
| N:HS |
systolic blood pressure |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
arterial blood pressure trait |
both |
125.0 days-132.0 days |
220 |
|
128.0 |
mmHg |
1.89 |
28.0 |
tail cuff piezoplethysmography |
|
|
6-8 readings per sitting |
11669 |
114 |
| M520/N |
systolic blood pressure |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
arterial blood pressure trait |
both |
125.0 days-132.0 days |
220 |
|
121.0 |
mmHg |
0.08 |
1.2 |
tail cuff piezoplethysmography |
|
|
6-8 readings per sitting |
11673 |
114 |
| MHS/Gib |
systolic blood pressure |
control condition |
Zagato et al., 2000, Hypertension, 36(5), 734-9 |
arterial blood pressure trait |
not specified |
84.0 days-112.0 days |
23 |
serial mean |
169.4 |
mmHg |
1.0 |
4.8 |
tail cuff piezoplethysmography |
4 readingsin 4 sessions |
|
W+W BP recorder |
11728 |
122 |
| BN/SsN |
systolic blood pressure |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
arterial blood pressure trait |
both |
125.0 days-132.0 days |
220 |
|
137.0 |
mmHg |
1.08 |
16.0 |
tail cuff piezoplethysmography |
|
|
6-8 readings per sitting |
11670 |
114 |
| F344/NRrrc |
systolic blood pressure |
control condition |
Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 |
arterial blood pressure trait |
both |
125.0 days-132.0 days |
220 |
|
149.0 |
mmHg |
1.08 |
16.0 |
tail cuff piezoplethysmography |
|
|
6-8 readings per sitting |
11677 |
114 |